0001209191-17-022048.txt : 20170321
0001209191-17-022048.hdr.sgml : 20170321
20170321163437
ACCESSION NUMBER: 0001209191-17-022048
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20170317
FILED AS OF DATE: 20170321
DATE AS OF CHANGE: 20170321
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EAGLE PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000827871
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 TICE BOULEVARD, SUITE 315
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
BUSINESS PHONE: 201-326-5300
MAIL ADDRESS:
STREET 1: 50 TICE BOULEVARD, SUITE 315
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
FORMER COMPANY:
FORMER CONFORMED NAME: EAGLE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19880120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Edlin Richard A.
CENTRAL INDEX KEY: 0001699676
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36306
FILM NUMBER: 17704558
MAIL ADDRESS:
STREET 1: C/O EAGLE PHARMACEUTICALS, INC.
STREET 2: 50 TICE BOULEVARD, SUITE 315
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2017-03-17
0
0000827871
EAGLE PHARMACEUTICALS, INC.
EGRX
0001699676
Edlin Richard A.
C/O EAGLE PHARMACEUTICALS, INC.
50 TICE BOULEVARD, SUITE 315
WOODCLIFF LAKE
NJ
07677
1
0
0
0
Common Stock
23400
D
Options (Right to Buy)
8.78
2022-07-11
Common Stock
2340
D
Immediately exercisable.
Exhibit List - Exhibit 24 - Power of Attorney
/s/ Scott Tarriff, Attorney-in-Fact
2017-03-21
EX-24.3_713431
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints
each of Scott Tarriff and David E. Riggs of Eagle Pharmaceuticals, Inc. (the
"Company") and each of Christopher Gerry (attorney), Mark Woodroffe (attorney),
and Jill Simon-Reisman (senior paralegal) of the law firm Cooley LLP ("Cooley"),
signing individually, the undersigned's true and lawful attorney-in fact and
agent to:
(1) prepare, execute on behalf of the undersigned, and submit to the U.S.
Securities and Exchange Commission (the "SEC") any documents necessary or
advisable to obtain EDGAR access codes or make any updates to the undersigned's
EDGAR access codes once obtained, enabling the undersigned to make electronic
filings of reports with the SEC;
(2) execute for and on behalf of the undersigned, an officer, director or holder
of 10% of more of a registered class of securities of the Company, Forms 3, 4
and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934,
as amended (the "Exchange Act") and the rules thereunder;
(3) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute such Form 3, 4 or 5,
complete and execute any amendment or amendments thereto, and timely file such
forms or amendments with the SEC and any stock exchange or similar authority;
and
(4) take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to such attorney-in-fact full power and authority
to do and perform any and every act and thing whatsoever requisite, necessary,
or proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorney-in-fact, in
serving in such capacity at the request of the undersigned, is not assuming, nor
is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned's holdings of and transactions in securities
issued by the Company, (b) revocation by the undersigned in a signed writing
delivered to the foregoing attorney-in-fact or (c) until such attorney-in-fact
shall no longer be employed by the Company or by Cooley, as applicable.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 28th day of February, 2017.
/s/ Richard A. Edlin
RICHARD A. EDLIN